Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation
- 19 May 2000
- Vol. 26 (6), 653-661
- https://doi.org/10.1016/s8756-3282(00)00280-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cellsBone, 1999
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Prostaglandin E2 Cooperates with TRANCE in Osteoclast Induction from Hemopoietic Precursors: Synergistic Activation of Differentiation, Cell Spreading, and FusionEndocrinology, 1999
- Prostaglandin E2, Interleukin 1 , and Tumor Necrosis Factor- Increase Human Osteoclast Formation and Bone Resorption in VitroEndocrinology, 1998
- Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell CulturesBiochemical and Biophysical Research Communications, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast FormationThe Journal of Experimental Medicine, 1997
- Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activityJournal of Cellular Biochemistry, 1994
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989
- Stimulation of prostaglandin E2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bonesBiochemical and Biophysical Research Communications, 1986